Day One Biopharmaceuticals Inc (NQ: DAWN )

14.72 +0.25 (+1.73%)

Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Day One Biopharmaceuticals Inc

< Previous 1 2 3 4 Next >

Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket

October 31, 2024

Via Benzinga

Bank of America Says Buy These 3 Stocks for a Double-Digit Rally

August 14, 2024

Despite fears of a recession roiling the markets, analysts say these are the best stocks to buy with an average upside potential of 72%.

Via InvestorPlace

Topics Economy

Exposures Economy

Meta To Rally Around 35%? Here Are 10 Top Analyst Forecasts For Thursday

August 01, 2024

Via Benzinga

DAWN Stock Earnings: Day One Biopharmaceutical Beats EPS, Beats Revenue for Q2 2024

July 30, 2024

DAWN stock results show that Day One Biopharmaceutical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Analyst Ratings for Day One Biopharmaceutical

November 07, 2023

Via Benzinga

The Latest Analyst Ratings for Day One Biopharmaceutical

September 12, 2023

Via Benzinga

Where Day One Biopharmaceutical Stands With Analysts

August 08, 2023

Via Benzinga

Analyst Ratings for Day One Biopharmaceutical

June 05, 2023

Via Benzinga

Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

July 25, 2024

Via Benzinga

Week In Review: FutureGen Sells mAb For IBD To AbbVie In $1.7 Billion Deal

June 22, 2024

FutureGen Biopharm out-licensed global rights for its next-gen TL1A antibody to AbbVie in a $1.7 billion agreement. Also, MabCare Therapeutics out-licensed global rights for its ADC targeting...

Via Talk Markets

DAWN Stock Earnings: Day One Biopharmaceutical Misses EPS for Q1 2024

May 06, 2024

DAWN stock results show that Day One Biopharmaceutical missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Dow Up Over 340 Points As Stocks Snap Back

October 30, 2023

The Dow Jones Industrial Average is building on this morning's gains, up 343 points at last look, while the S&P 500 and Nasdaq Composite sit firmly in the black as well.

Via Talk Markets

Topics Stocks

Exposures US Equities

Why Day One Biopharmaceuticals Stock Is Trading Higher Premarket Today

June 05, 2023

Via Benzinga

7 Analysts Have This to Say About Day One Biopharmaceutical

May 18, 2023

Via Benzinga

What 5 Analyst Ratings Have To Say About Day One Biopharmaceutical

April 25, 2023

Via Benzinga

Western Digital, JinkoSolar, Lumentum Holdings And Other Big Stocks Moving Higher On Monday

October 30, 2023

U.S. stocks traded higher, with the Nasdaq Composite gaining more than 100 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Exposures US Equities

12 Health Care Stocks Moving In Thursday's After-Market Session

October 26, 2023

Via Benzinga

$15M Bet On Day One Biopharmaceuticals? Check Out These 3 Stocks Insiders Are Buying

October 23, 2023

Although U.S. stocks closed lower on Friday, there were a few notable insider trades.

Via Benzinga

$3.6 Bet On Asana? Check Out These 4 Stocks Insiders Are Buying

June 13, 2023

Although US stocks closed higher on Monday, there were a few notable insider trades.

Via Benzinga

Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review

June 09, 2023

The Nasdaq held near 52-week highs while small caps ramped up.

Via Investor's Business Daily

Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session

June 05, 2023

Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding.

Via Benzinga

Why Shares of Day One Pharmaceuticals Are Up Monday

June 05, 2023

The clinical-stage biotech released early trial news regarding its lead therapy candidate.

Via The Motley Fool

ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Crashes

June 05, 2023

ImmunoGen and Day One gained Monday on their updates at a cancer treatment conference.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's Pre-Market Session

June 05, 2023

Via Benzinga

Why Mallinckrodt Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket

June 05, 2023

Gainers Forza X1, Inc. (NASDAQ: FRZA) shares rose 85.6% to $2.32 in pre-market trading after the company tweeted Friday 'Get ready for something extraordinary! Stay tuned!'

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

June 05, 2023

It's time to start the week off right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!

Via InvestorPlace

Day One Biopharmaceuticals, ImmunoGen And Other Big Stocks Moving Higher In Monday's Pre-Market Session

June 05, 2023

U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

April 25, 2023

Gainers

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2023

April 25, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

April 25, 2023

Via Benzinga

< Previous 1 2 3 4 Next >

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.